• Slide

    iCPS Breast Cancer Europe Roundtable

    23rd May 2019, Brussels

  • Slide

    iCPS Breast Cancer Europe Roundtable

    23rd May 2019, Brussels

  • Slide

    iCPS Breast Cancer Europe Roundtable

    23rd May 2019, Brussels

  • Slide

    iCPS Breast Cancer Europe Roundtable

    23rd May 2019, Brussels

  • Slide

    iCPS Breast Cancer Europe Roundtable

    23rd May 2019, Brussels

  • Slide

    iCPS Breast Cancer Europe Roundtable

    23rd May 2019, Brussels

  • Slide

    iCPS Breast Cancer Europe Roundtable

    23rd May 2019, Brussels

  • Slide

    iCPS Breast Cancer Europe Roundtable

    23rd May 2019, Brussels

  • Slide

    iCPS Breast Cancer Europe Roundtable

    23rd May 2019, Brussels

Overview:

Breast cancer is the most common cancer in European women, with 1 in 8 developing breast cancer before the age of 85. It has the highest mortality of any cancer in women worldwide, claiming the lives of more European women than any other cancer.

Causes include an increasingly sedentary lifestyle, weight gain, reproductive and sociological changes.

Continued investment in research and innovation is essential for improving diagnostic accuracy and developing novel therapeutic approaches.

The EU must raise greater awareness of breast cancer through educating, highlighting the risk factors and symptoms and promoting healthier lifestyles as a preventive measure.

This roundtable meeting will bring together EU policymakers, medical and clinical professionals, academic experts, healthcare players and patient groups, to examine the ongoing challenges in managing breast cancer more effectively and explore practical solutions in order to reach an EU-wide consensus and implement a forward action plan.

At this roundtable, participants will hear from high-level EU health officials and leading oncology experts, offering a variety of perspectives and recommendations through a series of open discussions.


Focus:
  • Updates from the European Commission Initiative on Breast Cancer
  • Data and information sharing between member states
  • Pan-European equity in cancer treatment: where are we?
  • Raising EU-wide awareness: education, prevention, further research and policy
  • Early detection & accurate screening and rapid diagnosis practices
  • Imaging for diagnosis – availability and accurate reading
  • Therapy options; the role of immunotherapy, chemotherapy, surgery, hormone therapy and radiotherapy
  • How can we develop cost-effective and equitable health care innovations?
  • Updates from Clinical Trials: Katherine Phase III, TAM-01 Phase III and GEICAM/CIBOMA Phase III
Participation:

This event is very restricted (only 30 seats are available) and interactive. All participants will have the opportunity to offer their perspective and make contributions throughout the day.

The Roundtable will also provide hours of networking time, including coffee breaks and lunch to ensure participants have the maximum possible time to establish and strengthen relationships, whilst exchanging ideas. 

Breast Cancer Report:

Following the Roundtable, a Breast Cancer Report will be published within the Government Gazetteour official Media Partner. Contributors include the European Commission, Members of the European Parliament, academic experts, industry and other key stakeholders.